Business
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Analysis: Is It The One You’re Looking For?
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) traded at $0.58 at close of the session on Friday, December 13 and made a downward move of -8.14% on its previous day’s price. Looking at the stock we see that its previous close was $0.63 and the beta (5Y
